These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26850485)

  • 21. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.
    Gupta S; Provenzale D; Llor X; Halverson AL; Grady W; Chung DC; Haraldsdottir S; Markowitz AJ; Slavin TP; Hampel H; ; Ness RM; Weiss JM; Ahnen DJ; Chen LM; Cooper G; Early DS; Giardiello FM; Hall MJ; Hamilton SR; Kanth P; Klapman JB; Lazenby AJ; Lynch PM; Mayer RJ; Mikkelson J; ; Peter S; Regenbogen SE; Dwyer MA; ; Ogba N
    J Natl Compr Canc Netw; 2019 Sep; 17(9):1032-1041. PubMed ID: 31487681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
    Childers KK; Maggard-Gibbons M; Macinko J; Childers CP
    JAMA Oncol; 2018 Jun; 4(6):876-879. PubMed ID: 29710084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical aspects of genetic counseling in breast cancer: lights and shadows.
    Christinat A; Pagani O
    Breast; 2013 Aug; 22(4):375-82. PubMed ID: 23673076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
    Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P
    Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Counseling the at risk patient in the BRCA1 and BRCA2 Era.
    Barnes-Kedar IM; Plon SE
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):341-66, vii. PubMed ID: 12108833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and benefits of diagnosing familial breast cancer.
    Heimdal K; Maehle L; Møller P
    Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial breast and ovarian cancer: genetic counseling and clinical management in Italy.
    Pasini B; Pierotti MA
    Dis Markers; 1999 Oct; 15(1-3):41-3. PubMed ID: 10595250
    [No Abstract]   [Full Text] [Related]  

  • 31. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing by cancer site: ovary.
    Weissman SM; Weiss SM; Newlin AC
    Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary breast/ovarian cancer--pitfalls in genetic counseling.
    Dagan E; Gershoni-Baruch R
    Clin Genet; 2001 Oct; 60(4):310-3. PubMed ID: 11683778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
    Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
    Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
    [No Abstract]   [Full Text] [Related]  

  • 35. Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancer.
    Pozzar RA; Hong F; Xiong N; Stopfer JE; Nayak MM; Underhill-Blazey M
    Fam Cancer; 2022 Jan; 21(1):35-47. PubMed ID: 33751319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH; Briasoulis E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.
    Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K
    Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inherited breast and ovarian cancers].
    Gerdes AM; Ejlertsen B
    Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic testing and interpretive complexity: a BRCA1 gene mutation example.
    Gogarty DS; Farrell MP; Gallagher DJ
    Ir J Med Sci; 2016 Nov; 185(4):955-957. PubMed ID: 25503966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.
    Obstet Gynecol; 2017 Sep; 130(3):e110-e126. PubMed ID: 28832484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.